Clinical trial reportThe New England journal of medicinePublished
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma
24 of 34 authors shown in byline order.
Regional connection
Verified An author affiliation on the Europe PMC record names Penn Medicine. Affiliation source
- Institution
- Penn Medicine
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- The New England journal of medicine
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Carcinoma, Renal Cell; Kidney Neoplasms; Adjuvants, Immunologic; Disease-Free Survival; Combined Modality Therapy; Survival Analysis; Double-Blind Method; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological
- PubMed ID
- 38631003
- Added to directory
- Source checked